ArticleFrontiers in pharmacology2022

Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.

Zhicheng Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.